Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cystic Fibrosis
Related studies linked through entity extraction aliases.
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
- Status
- COMPLETED
- Phase
- PHASE2
19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Comparison of 129Xe MRI With 19F MRI in CF Lung Disease
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)
- Status
- COMPLETED
- Phase
- N/A
GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of VX-659 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Outcomes in CF Patients Accessing Their Registry Health Records
- Status
- COMPLETED
- Phase
- NA
Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis
- Status
- COMPLETED
- Phase
- N/A
An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF)
- Status
- COMPLETED
- Phase
- NA
Modified Release Posaconazole in Patients With Cystic Fibrosis
- Status
- UNKNOWN
- Phase
- N/A